多参数MRI评估大鼠非酒精性脂肪性肝炎肝纤维化分期的整合与诊断效能及模型解释
研究用IVIM、IDEAL IQ、T2* mapping和T2 mapping在大鼠NASH模型中构建并验证预测模型,用于NASH诊断和肝纤维化分期,并用SHAP值解释模型。联合模型诊断NASH及晚期纤维化的AUC高于单参数,晚期纤维化AUC为0.929;FF值对NASH和晚期纤维化诊断贡献最大,T2值对肝纤维化诊断贡献最大,ADC值对肝硬化诊断贡献最大。
要点
- 联合mpMRI模型诊断NASH及晚期纤维化的AUC高于单参数,晚期纤维化AUC达0.929。
- SHAP分析显示FF值对NASH和晚期肝纤维化诊断贡献最大。
- T2值对肝纤维化诊断贡献最大,ADC值对肝硬化诊断贡献最大。
核心结论
- mpMRI可用于评估NASH背景下的肝纤维化严重程度,结合SHAP值分析有助于理解各mpMRI特征对预测模型的贡献。
研究设计与样本
- 动物实验:160只健康Sprague-Dawley大鼠分为对照组(n=24)和实验组(n=136),12周和16周组在最终喂养期前一个月腹腔注射四氯化碳4周,最终147只SD大鼠纳入肝纤维化评估,以病理检查确定肝纤维化分期为参考标准,采用IVIM、IDEAL IQ、T2* mapping和T2 mapping构建并验证预测模型。
诊断标准与关键数值
- 147只SD大鼠中84只诊断为NASH,组织学诊断无纤维化(F0)31只、早期肝纤维化(F1-F2)10只、晚期肝纤维化(F3-F4)43只;联合mpMRI预测模型诊断NASH及NASH相关肝纤维化分期的AUC高于单参数,晚期纤维化AUC为0.929。
临床应用与阅片要点
- 作者认为mpMRI可用于评估NASH背景下肝纤维化严重程度,结合SHAP值分析有助于理解各mpMRI特征对预测模型的贡献。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Multiparametric magnetic resonance imaging (mpMRI) techniques, including intravoxel incoherence motion (IVIM), iterative decomposition of water and fat with echo asymmetry and least-squares estimation quantification sequence (IDEAL IQ), T2* mapping and T2 mapping, were employed to develop and validate a predictive model for non-alcoholic steatohepatitis (NASH) diagnosis and liver fibrosis (LF) staging in rats. The combined model was interpreted using SHapley Additive exPlanations (SHAP) values for model interpretation.
MATERIALS AND METHODS: 160 healthy Sprague-Dawley (SD) rats were divided into control (n = 24) and experimental (n = 136) groups, and the 12-week and 16-week groups were injected intraperitoneally with carbon tetrachloride (CCl4) for 4 weeks, one month before the final feeding period. All rats were subjected to pathological examination to determine LF stage. Upon the study's completion, 147 SD rats were assessed for liver fibrosis.
RESULTS: 84 SD rats were diagnosed with NASH and 31, 10, and 43 rats were histologically diagnosed with no fibrosis (F0), early LF (F1-F2), and advanced LF (F3-F4). For diagnosis of NASH and staging of liver fibrosis associated with NASH, a combined mpMRI prediction model has a higher area under the receiver operating characteristic(ROC) curve (AUC) than uniparameters, especially in advanced stages of fibrosis, with an AUC of 0.929 for the combined model. In SHAP, the fat fraction(FF) value contributes most to the model for diagnosing NASH and advanced liver fibrosis, while the T2 value contributes most for diagnosing liver fibrosis and the apparent diffusion coefficient (ADC) value contributes most for diagnosing liver cirrhosis.
CONCLUSIONS: The mpMRI could be used to evaluate the severity of liver fibrosis in the context of NASH. Combined with SHAP value analysis, this approach can help to understand the contribution of each mpMRI feature to the predictive model.
引用
- Huang Z, Xia X, Liang Y, et al. Assessment and integration of multiparametric MRI for liver fibrosis staging in rat non-alcoholic steatohepatitis: Evaluation of diagnostic efficiency and model interpretation. Eur J Radiol. 2024. PMID: 39557004. doi:10.1016/j.ejrad.2024.111821
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。